NM_030787.4:c.58+19C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_030787.4(CFHR5):c.58+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000127 in 1,576,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
CFHR5
NM_030787.4 intron
NM_030787.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.266
Publications
0 publications found
Genes affected
CFHR5 (HGNC:24668): (complement factor H related 5) This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010]
CFHR5 Gene-Disease associations (from GenCC):
- C3 glomerulonephritisInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 1-196977741-C-T is Benign according to our data. Variant chr1-196977741-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1913903.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 16 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFHR5 | ENST00000256785.5 | c.58+19C>T | intron_variant | Intron 1 of 9 | 1 | NM_030787.4 | ENSP00000256785.4 | |||
CFHR5 | ENST00000699466.1 | c.-198+2627C>T | intron_variant | Intron 1 of 9 | ENSP00000514393.1 | |||||
CFHR5 | ENST00000699468.1 | c.-25+61C>T | intron_variant | Intron 1 of 5 | ENSP00000514394.1 | |||||
CFHR5 | ENST00000699467.1 | n.127+2153C>T | intron_variant | Intron 1 of 9 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151988Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4
AN:
151988
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251340 AF XY: 0.0000294 show subpopulations
GnomAD2 exomes
AF:
AC:
5
AN:
251340
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000112 AC: 16AN: 1424466Hom.: 0 Cov.: 25 AF XY: 0.0000127 AC XY: 9AN XY: 711136 show subpopulations
GnomAD4 exome
AF:
AC:
16
AN:
1424466
Hom.:
Cov.:
25
AF XY:
AC XY:
9
AN XY:
711136
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32880
American (AMR)
AF:
AC:
2
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25902
East Asian (EAS)
AF:
AC:
0
AN:
39436
South Asian (SAS)
AF:
AC:
2
AN:
85330
European-Finnish (FIN)
AF:
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
AC:
0
AN:
5680
European-Non Finnish (NFE)
AF:
AC:
12
AN:
1078096
Other (OTH)
AF:
AC:
0
AN:
59090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151988Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
4
AN:
151988
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74220
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41382
American (AMR)
AF:
AC:
2
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
AC:
0
AN:
10554
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68002
Other (OTH)
AF:
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 01, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.